The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders
International Cardiovascular Forum Journal · 2017
DOI: 10.17987/icfj.v10i0.454 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Cardiovascular Forum Journal, 2017. Verfasst von Andrew Coats. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
The 2016 ESC/HFA HF guidelines carry an important section on the treatments of co- morbidities in HF. One of the most common and most confusing, in terms of overlapping symptoms and interfering treatments is the presence of significant lung disorders. In this article is reviewed what the recent guidelines say about the management of lung disorders in the setting of HF, both HFrEF and HFpEF and expand on some of the practical advice.
Zitieren
APA
Coats, A. (2017). The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders. International Cardiovascular Forum Journal. https://doi.org/10.17987/icfj.v10i0.454
Vancouver
Coats A. The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders. International Cardiovascular Forum Journal. 2017. doi:10.17987/icfj.v10i0.454
BibTeX
@article{Coats2017,
author = {Coats, Andrew},
title = {The Management of Co-Morbidities in Patients with Heart Failure – Lung Disorders},
journal = {International Cardiovascular Forum Journal},
year = {2017},
doi = {10.17987/icfj.v10i0.454}
}
EUVIMED